secwatch / observer
8-K filed Jan 08, 2026 23:59 UTC ticker INDV CIK 0001625297
other_material confidence high sentiment positive materiality 0.80

Indivior provides FY2026 guidance: revenue $1.125B-$1.195B, Adj. EBITDA $535M-$575M

Indivior Pharmaceuticals, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-006993
form_type
8-K
ticker
INDV
cik
0001625297
company_name
Indivior Pharmaceuticals, Inc.
filed_at
2026-01-08T23:59:59+00:00
discovered_at
2026-05-14T18:02:35.673520+00:00
generated_at
2026-05-16T11:12:53.119833+00:00
sec_items
["7.01", "9.01"]
event_type
other_material
sentiment
positive
materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-006993
json_url
https://secwatch.observer/filing/0001193125-26-006993.json
markdown_url
https://secwatch.observer/filing/0001193125-26-006993.md
text_url
https://secwatch.observer/filing/0001193125-26-006993.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1625297/000119312526006993/0001193125-26-006993-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1625297/000119312526006993/d74661d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
Source: SEC EDGAR
accession 0001193125-26-006993

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.